J&J to buy cardiovascular technology Abiomed in $16.6B deal

Johnson & Johnson will spend $16.6 billion to buy cardiovascular technology company Abiomed to strengthen its medical device division.

source https://medicalxpress.com/news/2022-11-jj-cardiovascular-technology-abiomed-166b.html